One of the lesser known benefits of rhodiola rosea is that it not only features very few side effects, but that it also shows promise in minimizing the damage done by potent medical treatments such as chemotherapy. As usual, the evidence is preliminary and requires further corroboration, but at least it is promising enough that I believe more institutions should exercise greater interest in either verifying or fully refuting this promise.

If we can determine how Rhodiola rosea provided the benefits indicated in a few pilot studies, we may be able to devise new medications from it’s components that provide meaningful relief to many people suffering a great deal as they endure the side-effects of potent medications and aggressive treatment programs.

In this section you will learn how some pilot studies suggest this adaptogen could provide significant relief to people enduring chemotherapy.

Moving rhodiola research from theory and preliminary to proven or dis-proven is something I would love to see happen. I recognize that not all the preliminary promise will be proven valid or statistically significant, but I believe many people would be better off if we at least knew with some degree of certainty. And I believe this collection of research on Rhodiola rosea antioxidant and anti-carcinogenic effects should compel researchers to take this adaptogen more seriously.